Most cited papers from Venter Pharma (Spain)

Venter Pharma (Spain)

What are the most cited papers from Venter Pharma (Spain)?

The most cited paper from Venter Pharma (Spain) is "Noninvasive Diagnosis of Hypolactasia With 4-Galactosylxylose (Gaxilose)" (Juan J. Aragón, Carmen Hermida, Óscar H. Martínez-Costa et al., 2013), with 30 citations. Next come "Conditional deletion of Rcan1 predisposes to hypertension-mediated intramural hematoma and subsequent aneurysm and aortic rupture" (18) and "Phase I and Phase IB Clinical Trials for the Noninvasive Evaluation of Intestinal Lactase With 4-Galactosylxylose (Gaxilose)" (17).

Published FieldAccess

Showing 11 of 11 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Noninvasive Diagnosis of Hypolactasia With 4-Galactosylxylose (Gaxilose) Juan J. Aragón, Carmen Hermida, Óscar H. Martínez-Costa et al. · Journal of Clinical Gastroenterology	30 May 2013	30
2	Conditional deletion of Rcan1 predisposes to hypertension-mediated intramural hematoma and subsequent aneurysm and aortic rupture Silvia Villahoz, Paula Sofía Yunes-Leites, Nerea Méndez‐Barbero et al. · Nature Communications Open access	9 Nov 2018	18
3	Phase I and Phase IB Clinical Trials for the Noninvasive Evaluation of Intestinal Lactase With 4-Galactosylxylose (Gaxilose) Carmen Hermida, Pedro Ignacio Cardona Guerra, Óscar H. Martínez-Costa et al. · Journal of Clinical Gastroenterology	15 Jan 2013	17
4	Improvement and Validation of d ‐Xylose Determination in Urine and Serum as a New Tool for the Noninvasive Evaluation of Lactase Activity in Humans Carmen Hermida, Óscar H. Martínez-Costa, Guillermo Moreno Corrales et al. · Journal of Clinical Laboratory Analysis Open access	22 Mar 2014	11
5	Phase IV noninferiority controlled randomized trial to evaluate the impact on diagnostic thinking and patient management and the test–retest reproducibility of the Gaxilose test for hypolactasia diagnosis Carmen Monsalve-Hernando, Laura Varela Crespo, Blanca Ferreiro et al. · Medicine Open access	Nov 2018	9
6	Development of a new method for d-xylose detection and quantification in urine, based on the use of recombinant xylose dehydrogenase from Caulobacter crescentus Israel Sánchez‐Moreno, Eduardo García‐Junceda, Carmen Hermida et al. · Journal of Biotechnology Open access	30 Jul 2016	6
7	Simple and Practical Multigram Synthesis of d -Xylonate Using a Recombinant Xylose Dehydrogenase Israel Sánchez‐Moreno, Raúl Benito-Arenas, Pilar Montero-Calle et al. · ACS Omega Open access	18 Jun 2019	5
8	Analytical Validation of a New Enzymatic and Automatable Method for d-Xylose Measurement in Human Urine Samples Israel Sánchez‐Moreno, Carmen Monsalve-Hernando, Ana Godino et al. · BioMed Research International Open access	2017	3
9	Response to V. Martín‐Dominguez Et Al.: Re‐Evaluating the Diagnostic Approach to Lactose Malabsorption Cristian Camilo Medina Diaz, Bruno Marcelo Miguel, Cristina Ferreras · Neurogastroenterology & Motility	30 Nov 2025	2
10	Eficacia y seguridad del tratamiento con la combinación fija a dosis bajas de cinarizina 20 mg y dimenhidrinato 40 mg en el vértigo de origen diverso en la práctica clínica en España. Resultados del estudio VERTINEL Rafael Hijano-Esqué, Jesús Ignacio González Orodea, Javier Imaz Fandos et al. · Medicina Clínica Práctica Open access	5 Feb 2025	1
11	Circulating carbohydrate antigen Ca10H predicts favorable prognosis in colorectal cancer Pablo Mata-Martínez et al. · Scientific Reports Open access	9 Jul 2026	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.